Global Bleeding Disorders Market Research Report 2023

Report ID: 1983077 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Bleeding Disorders Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Plasma-derived Coagulation Factor Concentrates
        1.2.3 Recombinant Coagulation Factor Concentrates
        1.2.4 Desmopressin
        1.2.5 Antifibrinolytics
        1.2.6 Fibrin Sealants
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Bleeding Disorders Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hemophilia A
        1.3.3 Hemophilia B
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Bleeding Disorders Market Perspective (2017-2028)
    2.2 Bleeding Disorders Growth Trends by Region
        2.2.1 Bleeding Disorders Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Bleeding Disorders Historic Market Size by Region (2017-2022)
        2.2.3 Bleeding Disorders Forecasted Market Size by Region (2023-2028)
    2.3 Bleeding Disorders Market Dynamics
        2.3.1 Bleeding Disorders Industry Trends
        2.3.2 Bleeding Disorders Market Drivers
        2.3.3 Bleeding Disorders Market Challenges
        2.3.4 Bleeding Disorders Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Bleeding Disorders Players by Revenue
        3.1.1 Global Top Bleeding Disorders Players by Revenue (2017-2022)
        3.1.2 Global Bleeding Disorders Revenue Market Share by Players (2017-2022)
    3.2 Global Bleeding Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Bleeding Disorders Revenue
    3.4 Global Bleeding Disorders Market Concentration Ratio
        3.4.1 Global Bleeding Disorders Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Bleeding Disorders Revenue in 2021
    3.5 Bleeding Disorders Key Players Head office and Area Served
    3.6 Key Players Bleeding Disorders Product Solution and Service
    3.7 Date of Enter into Bleeding Disorders Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Bleeding Disorders Breakdown Data by Type
    4.1 Global Bleeding Disorders Historic Market Size by Type (2017-2022)
    4.2 Global Bleeding Disorders Forecasted Market Size by Type (2023-2028)
5 Bleeding Disorders Breakdown Data by Application
    5.1 Global Bleeding Disorders Historic Market Size by Application (2017-2022)
    5.2 Global Bleeding Disorders Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Bleeding Disorders Market Size (2017-2028)
    6.2 North America Bleeding Disorders Market Size by Country (2017-2022)
    6.3 North America Bleeding Disorders Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Bleeding Disorders Market Size (2017-2028)
    7.2 Europe Bleeding Disorders Market Size by Country (2017-2022)
    7.3 Europe Bleeding Disorders Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Bleeding Disorders Market Size (2017-2028)
    8.2 Asia-Pacific Bleeding Disorders Market Size by Country (2017-2022)
    8.3 Asia-Pacific Bleeding Disorders Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Bleeding Disorders Market Size (2017-2028)
    9.2 Latin America Bleeding Disorders Market Size by Country (2017-2022)
    9.3 Latin America Bleeding Disorders Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Bleeding Disorders Market Size (2017-2028)
    10.2 Middle East & Africa Bleeding Disorders Market Size by Country (2017-2022)
    10.3 Middle East & Africa Bleeding Disorders Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Novo Nordisk
        11.1.1 Novo Nordisk Company Detail
        11.1.2 Novo Nordisk Business Overview
        11.1.3 Novo Nordisk Bleeding Disorders Introduction
        11.1.4 Novo Nordisk Revenue in Bleeding Disorders Business (2017-2022)
        11.1.5 Novo Nordisk Recent Development
    11.2 Bayer
        11.2.1 Bayer Company Detail
        11.2.2 Bayer Business Overview
        11.2.3 Bayer Bleeding Disorders Introduction
        11.2.4 Bayer Revenue in Bleeding Disorders Business (2017-2022)
        11.2.5 Bayer Recent Development
    11.3 Baxter International
        11.3.1 Baxter International Company Detail
        11.3.2 Baxter International Business Overview
        11.3.3 Baxter International Bleeding Disorders Introduction
        11.3.4 Baxter International Revenue in Bleeding Disorders Business (2017-2022)
        11.3.5 Baxter International Recent Development
    11.4 Alnylam Pharmaceuticals
        11.4.1 Alnylam Pharmaceuticals Company Detail
        11.4.2 Alnylam Pharmaceuticals Business Overview
        11.4.3 Alnylam Pharmaceuticals Bleeding Disorders Introduction
        11.4.4 Alnylam Pharmaceuticals Revenue in Bleeding Disorders Business (2017-2022)
        11.4.5 Alnylam Pharmaceuticals Recent Development
    11.5 Pfizer
        11.5.1 Pfizer Company Detail
        11.5.2 Pfizer Business Overview
        11.5.3 Pfizer Bleeding Disorders Introduction
        11.5.4 Pfizer Revenue in Bleeding Disorders Business (2017-2022)
        11.5.5 Pfizer Recent Development
    11.6 Xenetic Biosciences
        11.6.1 Xenetic Biosciences Company Detail
        11.6.2 Xenetic Biosciences Business Overview
        11.6.3 Xenetic Biosciences Bleeding Disorders Introduction
        11.6.4 Xenetic Biosciences Revenue in Bleeding Disorders Business (2017-2022)
        11.6.5 Xenetic Biosciences Recent Development
    11.7 Bristol-Myers Squibb Company
        11.7.1 Bristol-Myers Squibb Company Company Detail
        11.7.2 Bristol-Myers Squibb Company Business Overview
        11.7.3 Bristol-Myers Squibb Company Bleeding Disorders Introduction
        11.7.4 Bristol-Myers Squibb Company Revenue in Bleeding Disorders Business (2017-2022)
        11.7.5 Bristol-Myers Squibb Company Recent Development
    11.8 Sanofi
        11.8.1 Sanofi Company Detail
        11.8.2 Sanofi Business Overview
        11.8.3 Sanofi Bleeding Disorders Introduction
        11.8.4 Sanofi Revenue in Bleeding Disorders Business (2017-2022)
        11.8.5 Sanofi Recent Development
    11.9 Janssen Global Services
        11.9.1 Janssen Global Services Company Detail
        11.9.2 Janssen Global Services Business Overview
        11.9.3 Janssen Global Services Bleeding Disorders Introduction
        11.9.4 Janssen Global Services Revenue in Bleeding Disorders Business (2017-2022)
        11.9.5 Janssen Global Services Recent Development
    11.10 Bioverativ
        11.10.1 Bioverativ Company Detail
        11.10.2 Bioverativ Business Overview
        11.10.3 Bioverativ Bleeding Disorders Introduction
        11.10.4 Bioverativ Revenue in Bleeding Disorders Business (2017-2022)
        11.10.5 Bioverativ Recent Development
    11.11 Amgen
        11.11.1 Amgen Company Detail
        11.11.2 Amgen Business Overview
        11.11.3 Amgen Bleeding Disorders Introduction
        11.11.4 Amgen Revenue in Bleeding Disorders Business (2017-2022)
        11.11.5 Amgen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Bleeding Disorders Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Plasma-derived Coagulation Factor Concentrates
    Table 3. Key Players of Recombinant Coagulation Factor Concentrates
    Table 4. Key Players of Desmopressin
    Table 5. Key Players of Antifibrinolytics
    Table 6. Key Players of Fibrin Sealants
    Table 7. Key Players of Others
    Table 8. Global Bleeding Disorders Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Bleeding Disorders Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Bleeding Disorders Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Bleeding Disorders Market Share by Region (2017-2022)
    Table 12. Global Bleeding Disorders Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Bleeding Disorders Market Share by Region (2023-2028)
    Table 14. Bleeding Disorders Market Trends
    Table 15. Bleeding Disorders Market Drivers
    Table 16. Bleeding Disorders Market Challenges
    Table 17. Bleeding Disorders Market Restraints
    Table 18. Global Bleeding Disorders Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Bleeding Disorders Market Share by Players (2017-2022)
    Table 20. Global Top Bleeding Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bleeding Disorders as of 2021)
    Table 21. Ranking of Global Top Bleeding Disorders Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Bleeding Disorders Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Bleeding Disorders Product Solution and Service
    Table 25. Date of Enter into Bleeding Disorders Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Bleeding Disorders Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Bleeding Disorders Revenue Market Share by Type (2017-2022)
    Table 29. Global Bleeding Disorders Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Bleeding Disorders Revenue Market Share by Type (2023-2028)
    Table 31. Global Bleeding Disorders Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Bleeding Disorders Revenue Market Share by Application (2017-2022)
    Table 33. Global Bleeding Disorders Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Bleeding Disorders Revenue Market Share by Application (2023-2028)
    Table 35. North America Bleeding Disorders Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Bleeding Disorders Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Bleeding Disorders Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Europe Bleeding Disorders Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Asia-Pacific Bleeding Disorders Market Size by Region (2017-2022) & (US$ Million)
    Table 40. Asia-Pacific Bleeding Disorders Market Size by Region (2023-2028) & (US$ Million)
    Table 41. Latin America Bleeding Disorders Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Latin America Bleeding Disorders Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Middle East & Africa Bleeding Disorders Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Middle East & Africa Bleeding Disorders Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Novo Nordisk Company Detail
    Table 46. Novo Nordisk Business Overview
    Table 47. Novo Nordisk Bleeding Disorders Product
    Table 48. Novo Nordisk Revenue in Bleeding Disorders Business (2017-2022) & (US$ Million)
    Table 49. Novo Nordisk Recent Development
    Table 50. Bayer Company Detail
    Table 51. Bayer Business Overview
    Table 52. Bayer Bleeding Disorders Product
    Table 53. Bayer Revenue in Bleeding Disorders Business (2017-2022) & (US$ Million)
    Table 54. Bayer Recent Development
    Table 55. Baxter International Company Detail
    Table 56. Baxter International Business Overview
    Table 57. Baxter International Bleeding Disorders Product
    Table 58. Baxter International Revenue in Bleeding Disorders Business (2017-2022) & (US$ Million)
    Table 59. Baxter International Recent Development
    Table 60. Alnylam Pharmaceuticals Company Detail
    Table 61. Alnylam Pharmaceuticals Business Overview
    Table 62. Alnylam Pharmaceuticals Bleeding Disorders Product
    Table 63. Alnylam Pharmaceuticals Revenue in Bleeding Disorders Business (2017-2022) & (US$ Million)
    Table 64. Alnylam Pharmaceuticals Recent Development
    Table 65. Pfizer Company Detail
    Table 66. Pfizer Business Overview
    Table 67. Pfizer Bleeding Disorders Product
    Table 68. Pfizer Revenue in Bleeding Disorders Business (2017-2022) & (US$ Million)
    Table 69. Pfizer Recent Development
    Table 70. Xenetic Biosciences Company Detail
    Table 71. Xenetic Biosciences Business Overview
    Table 72. Xenetic Biosciences Bleeding Disorders Product
    Table 73. Xenetic Biosciences Revenue in Bleeding Disorders Business (2017-2022) & (US$ Million)
    Table 74. Xenetic Biosciences Recent Development
    Table 75. Bristol-Myers Squibb Company Company Detail
    Table 76. Bristol-Myers Squibb Company Business Overview
    Table 77. Bristol-Myers Squibb Company Bleeding Disorders Product
    Table 78. Bristol-Myers Squibb Company Revenue in Bleeding Disorders Business (2017-2022) & (US$ Million)
    Table 79. Bristol-Myers Squibb Company Recent Development
    Table 80. Sanofi Company Detail
    Table 81. Sanofi Business Overview
    Table 82. Sanofi Bleeding Disorders Product
    Table 83. Sanofi Revenue in Bleeding Disorders Business (2017-2022) & (US$ Million)
    Table 84. Sanofi Recent Development
    Table 85. Janssen Global Services Company Detail
    Table 86. Janssen Global Services Business Overview
    Table 87. Janssen Global Services Bleeding Disorders Product
    Table 88. Janssen Global Services Revenue in Bleeding Disorders Business (2017-2022) & (US$ Million)
    Table 89. Janssen Global Services Recent Development
    Table 90. Bioverativ Company Detail
    Table 91. Bioverativ Business Overview
    Table 92. Bioverativ Bleeding Disorders Product
    Table 93. Bioverativ Revenue in Bleeding Disorders Business (2017-2022) & (US$ Million)
    Table 94. Bioverativ Recent Development
    Table 95. Amgen Company Detail
    Table 96. Amgen Business Overview
    Table 97. Amgen Bleeding DisordersProduct
    Table 98. Amgen Revenue in Bleeding Disorders Business (2017-2022) & (US$ Million)
    Table 99. Amgen Recent Development
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Bleeding Disorders Market Share by Type: 2021 VS 2028
    Figure 2. Plasma-derived Coagulation Factor Concentrates Features
    Figure 3. Recombinant Coagulation Factor Concentrates Features
    Figure 4. Desmopressin Features
    Figure 5. Antifibrinolytics Features
    Figure 6. Fibrin Sealants Features
    Figure 7. Others Features
    Figure 8. Global Bleeding Disorders Market Share by Application in 2021 & 2028
    Figure 9. Hemophilia A Case Studies
    Figure 10. Hemophilia B Case Studies
    Figure 11. Others Case Studies
    Figure 12. Bleeding Disorders Report Years Considered
    Figure 13. Global Bleeding Disorders Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Bleeding Disorders Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Bleeding Disorders Market Share by Region: 2021 VS 2028
    Figure 16. Global Bleeding Disorders Market Share by Players in 2021
    Figure 17. Global Top Bleeding Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bleeding Disorders as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Bleeding Disorders Revenue in 2021
    Figure 19. North America Bleeding Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America Bleeding Disorders Market Share by Country (2017-2028)
    Figure 21. United States Bleeding Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Bleeding Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Bleeding Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Bleeding Disorders Market Share by Country (2017-2028)
    Figure 25. Germany Bleeding Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Bleeding Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Bleeding Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Bleeding Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Bleeding Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Bleeding Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Bleeding Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Bleeding Disorders Market Share by Region (2017-2028)
    Figure 33. China Bleeding Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan Bleeding Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea Bleeding Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia Bleeding Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India Bleeding Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia Bleeding Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Bleeding Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Bleeding Disorders Market Share by Country (2017-2028)
    Figure 41. Mexico Bleeding Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil Bleeding Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Bleeding Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Bleeding Disorders Market Share by Country (2017-2028)
    Figure 45. Turkey Bleeding Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia Bleeding Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Novo Nordisk Revenue Growth Rate in Bleeding Disorders Business (2017-2022)
    Figure 48. Bayer Revenue Growth Rate in Bleeding Disorders Business (2017-2022)
    Figure 49. Baxter International Revenue Growth Rate in Bleeding Disorders Business (2017-2022)
    Figure 50. Alnylam Pharmaceuticals Revenue Growth Rate in Bleeding Disorders Business (2017-2022)
    Figure 51. Pfizer Revenue Growth Rate in Bleeding Disorders Business (2017-2022)
    Figure 52. Xenetic Biosciences Revenue Growth Rate in Bleeding Disorders Business (2017-2022)
    Figure 53. Bristol-Myers Squibb Company Revenue Growth Rate in Bleeding Disorders Business (2017-2022)
    Figure 54. Sanofi Revenue Growth Rate in Bleeding Disorders Business (2017-2022)
    Figure 55. Janssen Global Services Revenue Growth Rate in Bleeding Disorders Business (2017-2022)
    Figure 56. Bioverativ Revenue Growth Rate in Bleeding Disorders Business (2017-2022)
    Figure 57. Amgen Revenue Growth Rate in Bleeding Disorders Business (2017-2022)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novo Nordisk
Bayer
Baxter International
Alnylam Pharmaceuticals
Pfizer
Xenetic Biosciences
Bristol-Myers Squibb Company
Sanofi
Janssen Global Services
Bioverativ
Amgen
Frequently Asked Questions
Bleeding Disorders report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Bleeding Disorders report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Bleeding Disorders report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Boat Davits

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More